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Abstract
Objectives: To evaluate the different therapeutic possibilities for treating Sleep Apnea/ Hypoapnea Syndrome 
(SAHS), as well as the effectiveness of such treatments, and to evaluate the epidemiological and clinical aspects 
of this syndrome. 
Study design: We carried out a meta-analytical, observational and retrospective study by selecting a total of 13 
articles, which provided a sample size of 642 diagnosed cases of SAHS.
Results: SAHS was more prevalent among males (88.7%) and the average age of diagnosis was 49.75 years old.  In 
the majority of cases, these patients were found to be overweight, with an average body mass index of 28.32 Kg/
m². The average apnea / hypoapnea index was 31.64 apneas / hypoapneas per hour, which is therefore considered 
to be a moderate type of SAHS. The therapeutic approach involved intraoral mandibular advancement devices in 
77.96% of the cases, followed by 16% of the patients who were treated with continuous positive airway pressure 
devices during sleep (CPAP), and lastly, 7% underwent surgical treatment.
Conclusions: SAHS is a complex clinical condition that requires a multidisciplinary team in order to diagnose and 
treat it. There are several therapeutic possibilities available to professionals, which have obtained highly satisfac-
tory results.
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Introduction
Obstructive sleep apnea syndrome (OSAS) is a hidden 
and potentially deadly sleep disorder in which there is a 
high incidence, and it is a very important public health 
issue as well as a social issue.  
OSAS is characterized by a periodic collapse of the up-
per airways while sleeping, mainly during the REM 
phase, which causes an absence (apnea) or decrease (hy-
poapnea) of the airflow in the lungs despite the patient s´ 
persistent respiratory effort.
The prevalence of OSAS in western countries affects 
approximately 5% of adults, ranging from 3 to 10% of 
the male population in Spain, compared to 2% of the 
female population (1).
An adequate clinical history and an exhaustive physical 
exam will enable identifying patients who suffer OSAS. 
Polysomnography is used as the primary method for di-
agnosing SAHS, and is often used in conjunction with a 
lateral teleradiography of the head followed by a cepha-
lometric study, which is a good indicator for defining 
and identifying where the obstruction is and even for 
helping to decide the therapeutic course of treatment to 
follow (1-4). 
The apnea-hypoapnea index (AHI) is used by many pro-
fessionals for confirming the diagnosis and quantifying 
the severity of the sleep disorder. The AHI is calculated 
by adding up the number of apneas (breathing inter-
ruptions lasting 10 seconds of more) and hypoapneas 
(the decrease, but not the complete interruption of the 
air flow which causes a 3% drop in oxygen saturation 
or sleep disturbances) during the study, divided by the 
number of hours slept (1-5).
As for treatment, first, one must take a series of general 
steps towards losing weight, getting rid of habits such 
as using alcohol, tobacco or maintaining an irregular 
schedule, and must decrease the use of hypnotic or 
sedative drugs. Medical treatment consists of the CPAP, 
which is based on a high pressure device that releases 
an intense and continuous flow of air through a nose 
mask that the patient must wear while sleeping. In the 
dental treatment, there are a number of intraoral devices 
which, according to their mechanism of action, can be 
classified as: tongue retaining device (TRD), adjustable 
soft palate lifter (ASPL) and repositioning of the uvu-
la, and mandibular advancement devices (MAD). The 
surgical alternatives vary greatly and range from a tra-
cheostomy, surgery of the nasal passages, uvulopalat-
opharyngoplasty, surgery on the geniohyoid complex, 
glossectomy, and orthognathic surgery.
The objectives of our study are to evaluate the different 
therapeutic possibilities for treating OSAS as well as 
the effectiveness of these treatments, and to evaluate the 
clinical and epidemiological aspects of this syndrome.
Material and Methods
A meta-analytical, observational and retrospective 
study was carried out based on the results obtained 
from a bibliographic search in PubMed. The key words 
used were: “Sleep apnea syndrome”, “obesity”, “cepha-
lometric analysis”, and “positive pressure ventilation”. 
We reviewed a total of 30 articles, ranging from the year 
1996 to 2009, which had to meet the following established 
criteria in order to be included:  articles that present more 
than 10 clinical cases of OSAS diagnosed by polysom-
nigraphy and/or cephalometric study, and that evaluate 
both the treatment used as well as its effectiveness.
The 13 articles selected provided a sample size of 642 
cases, which were treated using descriptive statistics to 
evaluate the following parameters (Table 1):
Age: The age of the subjects was recorded at the time of 
the diagnosis.
Sex: The sex of the patient was recorded and a com-
parison between the occurrences of this disorder with 
respect to gender was also evaluated.
Type of OSAS: The subjects were categorized into groups 
and the frequency of occurrence was evaluated in each 
group, comparing it with the apnea/ hypoapnea index. 
Apnea/ Hypoapnea Index (AHI): The average of all of 
the subjects was recorded as well as their ranges, and 
then compared with the type of apnea. 
Body Mass Index (BMI): The average for all of the pa-
tients was obtained, as well as the ranges, and the de-
gree of obesity was compared with the type of OSAS.
Treatment: The most common therapeutic approach 
used for the different patients as well as the effective-
ness of such treatment was analyzed.
Results
The results of the population studied was variable ac-
cording to each parameter indicated, given that it was 
impossible to obtain all of the data on each one of the 
individuals, projecting the following results:
With respect to the age variable, there were 539 patients 
evaluated at the time of the diagnosis, ranging in age 
from 23 to 78 years old (a range of 55 years), with the 
average age of diagnosis being 49.74 years old. 
As far as the patient s´ sex, the OSAS in the population 
studied was more prevalent among males, reporting 362 
cases and accounting for 88.7% of the group, compared 
to 11.27% or 46 cases among females. The ratio was 
7.86 males per female (Fig. 1).
As far as the type of OSAS, 391 patients were diagnosed 
with moderate OSAS, representing 45.7% of the group 
and making it the most prevalent type, which is consis-
tent with the AHI as can be observed below. The severe 
type of OSAS comes in second place in terms of preva-
lence and accounts for 36.1% of the population studied; 
lastly, those who suffer a mild type represent 18.2% of 
the cases. 
Med Oral Patol Oral Cir Bucal. 2010 Jul 1;15 (4):e605-10.                                                                                                                                                                               Treatment of sleep apnea
e607
Table 1. Effectiveness of the different treatments (Oral Mandibular Advancement Devices – OMAD, Continuous Positive 
Air Pressure – CPAP, Surgical Treatment - ST) depending on the apnea / hypoapnea index (AHI). 
AUTHOR No. of CASES AHI TREATMENT EFFECTIVENESS
Cohen 1998 (4)
25
A: 15
B: 10
A: 43.7
B:11.3 OMAD
A: 90%
B: 60%
Rose et al. 
2002 (5) 26 17.8 OMAD 81%
Tegelberg et al. 
2003 (6)
74
A: 38
B: 36
A: 16.2±2.9
B: 18.9±4.7
A: OMAD
B: OMAD
  A: 79%.
 B:73%
Hoekema et al.  
2007 (7)
103
A:52
B:51
A:  40.8±28
B:  38±29.8
A: CPAP.
B: OMAD
A: 86%
 B: 79.6%
Santos Junior 
et al. 2007 (8) 10      12.38±4.40 ST 70%
Lye et al. 2008 (9) 15 69.12 ST 86.7%
Hoekema et al. 
2008 (10)
103
A:52
B:51
 A:  39.4±30.8.
B:  40.3±27.6
 A: OMAD
     B: CPAP
A: 76.5%
B: 82.7%
Gindre et al. 2008 
(11)
66
A:50
B:16
A: 42±20
B:  29±19 OMAD 70%
Bruno Carlo et al. 
2008 (12) 20             35 ST 100%
Doff et al. 2009 
(13) 52      35.8±27.5 OMAD 81%
Aarab et al. 2009 
(14) 17 21.6±11.1 OMAD 70%
Campbell et al. 
2009 (15)
28
A:12
B:16
  A:  26.5±12
  B:  25.4±7.4 OMAD 71%
Ghazal et al. 
2009 (16)
103
A: 51
B: 52
     A: 32±6
     B: 37±8 OMAD
A: 51%
   B: 79.2%
In this manner and consistent with that reported above, 
when recording the AHI, we obtained values that ranged 
dramatically: from 7.8 to 112 (a range of 104.2 apneas-
hypoapneas per hour). The average value obtained in the 
642 patients studied was 31.64 apneas-hypoapneas per 
hour, therefore constituting a moderate type of OSAS.
As for the BMI, 494 patients presented a BMI between 
26 and 68 at the time of being diagnosed, with a range 
of 42 Kg/m² and the average value being 28.32 Kg/m². 
Based on the classification used by the WHO, we were 
able to observe that the majority of the subjects were 
overweight.Fig. 1. Distribution by sex 
Mujeres: Females     Hombres: Males 
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For 76.94% of the patients or in 494 cases, the most com-
mon therapeutic approach involved the use of intraoral 
devices designed to produce a mandibular advance-
ment. A total of 103 subjects or 16% of the patients were 
treated with CPAP (continuous positive airway pressure 
devices during sleep), whereas 7% (45 patients) under-
went a mono or bimaxillary orthognathic surgery and/
or genioplasties. As for the effectiveness of the treat-
ments, we were able to observe that the surgical treat-
ment obtained an 85.56% success rate, followed by an 
84.35% success rate in treatment using CPAP, whereas 
treatment with intraoral mandibular advancement de-
vices were successful in 73.94% of the cases (Fig. 2).
Discussion 
From a clinical perspective, OSAS is characterized by 
the triad of daytime fatigue (hypersomnia), snoring and 
pauses in breathing at night which is generally referred 
by the spouse or partner. These symptoms are simul-
taneously present in almost all those affected by this 
sleep disorder. In addition, other neuropsychiatric and 
cardiorespiratory disorders are common, which are se-
condary to the constant oxygen desaturations and to the 
temporary and subconscious sleep disturbances that are 
caused by the apneas (1).
As for the age of the patient when diagnosed with 
OSAS, authors such as Tegelberg et al. (6) consider the 
most common period to be between the fourth and fifth 
decades of life, an assertion that is consistent with our 
study in which the patients averaged 49.74 years of age 
when they were diagnosed. Despite this, authors such as 
Cohen (4) set a fairly large age range that usually goes 
from 23 to 78 years old. 
As for the sex of the patient, there is a consensus among 
the authors consulted, supported by the fact that 88.7% 
of the subjects included in our study were male, com-
pared to 11.3% who were female (7-16). There are vari-
ous studies in which all of the patients were male, such 
as the case reported by Battagel et al. (3). Only the 
study by Van Haute et al. (17) contrasts the previous 
results, given that among their patients diagnosed with 
OSAS associated with metabolic disorders, particularly 
acromegaly, they estimate a slightly higher percentage 
(57.41%) in females compared with males. 
Clinically, OSAS can be divided into three categories 
described by the American Sleep Apnea Association, 
and are closely connected to the AHI; they are classi-
fied as: mild form when the AHI is between 5 and 20, 
moderate form if it is between 21 and 40, and severe 
form if it is more than 40. Based on this classification, 
when evaluating the prevalence of each one of the clini-
cal forms in our study, we found that the most common 
type is moderate OSAS, which accounts for 45.7% of 
the cases. In this respect, it is worth noting that in the 
study conducted by Bruno Carlo et al. (12), patients who 
had an average AHI of 35 apneas/ hypoapneas per hour 
were classified as having a severe OSAS, which is why 
based on the classification previously mentioned, we 
decided to group it with the moderate type. 
As for the apnea/ hypoapnea index (AHI), both our 
study as well as the rest of the literature agrees that this 
variable is the one to be used for diagnosing OSAS, gi-
ven that an AHI above 5 apneas/ hypoapneas per hour 
is considered to be pathological (1-3).
As for the body mass index (BMI), it should be noted 
that the majority of these patients present a problem as-
sociated with obesity, sometimes in combination with 
the use of alcohol and tobacco. In our case, all of the 
authors selected for our study presented subjects who 
                                                                             

Fig. 2. Evaluation of the effectiveness according to surgical treatment, oral device and 
continuous positive air pressure (CPAP).
Eficacia: Effectiveness
Quirúrgico: Surgical treatment
CPAP: Continuous positive air pressure
D. Oral: Oral device
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were overweight according to the classification by the 
WHO, given that the average BMI was 28.32 Kg/m². We 
can also infer that the type of OSAS is closely related 
to the degree of obesity, and that this plays a role when 
selecting the type of therapeutic procedure to be imple-
mented.  Along this same line, Lye et al. (9) present a 
group of 15 patients with a severe type of OSAS ac-
companied by an average BMI of 32.1 Kg/m², which is 
a significant degree of obesity; after other treatments 
such as CPAP were unsuccessful, they opted for a more 
aggressive course of treatment, such as bimaxillary ad-
vancement orthognathic surgery.
The treatment of OSAS is considered multifactorial and 
must address several issues that need not be mutually 
exclusive. In the literature, there is a consensus on the 
need to first take a series of general steps in order to lose 
weight, get regular physical exercise, establish a sche-
dule that enables a good sleep hygiene, and eliminate 
the use of alcohol and other hypnotic or sedative drugs. 
If we focus on more specific treatments, there is a wide 
variety of therapies, although none of them are com-
pletely satisfactory (1,2).
As far as the effectiveness of the medical treatment, we 
obtained a success rate of 84.35% in our study. Never-
theless and despite this, other authors such as the case 
of Aarab et al. (14) or Rose et al. (5) report that there is a 
poor tolerance to the treatment over the long term given 
that it involves a chronic dependency of a machine that 
only produces a symptomatic improvement without 
curing the disorder. Along this same line, Gindre et al. 
(11) report similar findings in which the patients in the 
study had been previously treated with CPAP, obtaining 
poor results and a high rate of those who abandoned the 
treatment, finally opting for the mandibular advance-
ment device. 
In the odontological treatment, there are intraoral de-
vices that have recently been gaining in popularity. The 
most frequently used are those designed to bring about a 
mandibular advancement that would enable an increase 
in the size of the air passages. The success obtained in 
our study was 73.94%, not being exempt of secondary 
effects as affirmed by Campbell et al. (15), who point 
out hypersalivation, dryness of the mucosa and altera-
tions of the TMJ in their patients. However, these results 
differ from those obtained by Jauhar et al. (18), given 
that it was only effective in 40% of the cases. Ghazal 
et al. (16) also evaluated the secondary effects at the 
dental level, concluding that the majority of the effects 
involve the incisors, and in 47.6% of the cases there was 
a significant reduction in the overbite.
The choice of surgical treatment versus other more 
conservative courses of treatment creates a certain di-
lemma given that there is no clear-cut response protocol 
for patients with this type of pathology. In our study, 
the techniques used were orthognathic surgery with 
mono or bimaxillary advancement, possibly combined 
with genioplasty, being the course of treatment that was 
most effective and obtained a success rate of 85.56%. 
Similar results were reported by Foltán et al. (19) whose 
success rate was 74%, using a technique that combines 
genioplasty with hyoid myotomy in patients with mild 
or moderate SAHS and with a BMI under 30 Kg/m². 
A study conducted by Santos et al. (8) also reported 
similar results in which an effective rate of 70% was 
obtained when treating patients who were slightly over-
weight and had moderate sleep apnea.  As far as orthog-
nathic surgery, currently considered to be the optimum 
technique used in patients with severe SAOS, authors 
such as Thompson et al. (20) reported highly satisfac-
tory results similar to ours.  
Nevertheless, SAOS is a complex clinical condition that 
requires a multidisciplinary team for making the diag-
nosis as well as for treating it. 
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